Go Pro
→ NASA's ISS Replacement Could Go to This Tiny Space Firm (From Behind the Markets) (Ad)tc pixel Free DMAA Stock Alerts

Drugs Made In America Acquisition (DMAA) Stock Chart & Stock Price History

Drugs Made In America Acquisition logo
$10.82 -0.03 (-0.28%)
As of 09/23/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Drugs Made In America Acquisition Stock Price Performance

The Drugs Made In America Acquisition (DMAA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.24%, with a year-to-date return of 4.63%. In the past month, the stock has increased 0.98%, reflecting recent market activity.

As of the latest close, Drugs Made In America Acquisition traded at $10.85 with a market cap of $263.41 million and volume of 239 shares.

Receive DMAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.09%
1 Month
Performance
+0.98%
3 Month
Performance
+1.97%
Year-To-Date
Performance
+4.63%
1 Year
Performance
+5.24%

DMAA Stock Chart for Thursday, September, 24, 2026

DMAA Chart by TradingView

Drugs Made In America Acquisition Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/23/2026$10.85$10.85$10.85$10.85239 shs$263.41 million
09/22/2026$10.85$10.85$10.85$10.82657 shs$263.44 million
09/21/2026$10.84$10.85
+0.09%		$10.85$10.842,606 shs$263.44 million
09/18/2026$10.84$10.84$10.84$10.84352 shs$263.20 million
09/17/2026$10.84$10.84$10.84$10.82921 shs$263.16 million
09/16/2026$10.84$10.84$10.84$10.822,114 shs$263.20 million
09/15/2026$10.83$10.84
+0.09%		$10.84$10.841,551 shs$263.20 million
09/14/2026$10.80$10.83
+0.28%		$10.86$10.80164,452 shs$262.92 million
09/11/2026$10.80$10.80$10.80$10.80802 shs$262.19 million
09/10/2026$10.80$10.80$10.80$10.7934,843 shs$262.22 million
09/09/2026$10.79$10.80
+0.09%		$10.80$10.793,235 shs$262.22 million
09/08/2026$10.76$10.79
+0.33%		$10.79$10.76519,523 shs$261.95 million
09/07/2026$10.76$10.76$10.77$10.7529,709 shs$261.13 million
09/04/2026$10.75$10.76
+0.05%		$10.77$10.7529,709 shs$261.10 million
09/03/2026$10.77$10.75
-0.14%		$10.75$10.75109 shs$261.01 million
09/02/2026$10.76$10.77
+0.05%		$10.77$10.7518,220 shs$261.37 million
09/01/2026$10.75$10.76
+0.09%		$10.76$10.7527,988 shs$261.22 million
08/31/2026$10.75$10.75$10.76$10.744,130 shs$261.01 million
08/28/2026$10.76$10.75
-0.05%		$10.75$10.744,228 shs$261.01 million
08/27/2026$10.76$10.76
-0.05%		$10.76$10.7516,916 shs$261.13 million
08/26/2026$10.76$10.76
+0.05%		$10.76$10.7512,300 shs$261.22 million
08/25/2026$10.75$10.76
+0.09%		$10.76$10.7415,135 shs$261.13 million
08/24/2026$10.75$10.75
-0.05%		$10.76$10.7425,141 shs$260.89 million
Related Companies

This page (NASDAQ:DMAA) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
On October 7th, your “safest” assets are at risk
Jeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...
Brownstone Research | Sponsoredtc pixel
The REAL Reason 2,000 Missiles Rained on Iran
Two private meetings with U.S. Congressmen and weeks of research point to a surprising explanation for the rec...
Behind the Markets | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel